Dr. Jose A Bermudez, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 301 Hall St, Monroe, LA 71201 Phone: 318-966-6565 Fax: 318-966-6566 |
Dr. Jorge Eduardo Alvernia-silva, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1908 Royal Ave, Monroe, LA 71201 Phone: 318-509-8808 Fax: 318-509-8769 |
Dr. Carlton Russ Greer, M.D./NEUROSURGEON Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 414 Wood St, Monroe, LA 71201 Phone: 318-323-9433 Fax: 318-361-2680 |
Dr. Bernie G. Mchugh Jr., M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 312 Grammont St Ste 404, Monroe, LA 71201 Phone: 318-323-1809 Fax: 318-323-2668 |
Dr. Marshall Arbuthnot Cain, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2485 Tower Dr, Suite 9, Monroe, LA 71201 Phone: 318-600-4159 Fax: 318-600-4473 |
News Archive
Andrzej Dlugosz, M.D., a professor of dermatology in the U-M Medical School, and colleagues at the University of Michigan and the National Cancer Institute examined the functions of the Hedgehog (Hh) signaling pathway in basal cell carcinoma – the most common form of cancer – and uncovered a subset of tumor cells that were resistant to inhibition of the Hedgehog pathway.
In the March 15 Morning Edition, "Economists, Dems Differ On Who's To Blame For Insurers' Rate Hikes," KHN omitted a word in a summary of the Milwaukee Journal Sentinel coverage.
Among premature, very low-birth-weight infants requiring a transfusion, use of fresh red blood cells (RBCs) compared with standard RBC transfusion practice did not improve clinical outcomes that included rates of complications or death, according to a study in the October 10 issue of JAMA.
BioCryst Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, 5,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
GE Healthcare, a unit of General Electric Company announced that it has entered into an agreement to acquire the assets of Orbotech Medical Solutions Ltd., a subsidiary of Orbotech Ltd. (Orbotech), and a manufacturer of cadmium zinc telluride (CZT) detectors used in GE Healthcare's innovative Alcyone nuclear medicine technology.
› Verified 3 days ago